Exabis Library
Welcome to the e-CCO Library!
P446: Long-term Clinical Effectiveness And Stoma Outcome Of Fecal Diversion In Refractory Crohn’s Proctitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P446: Patient and public involvement in a clinical trial for perianal Crohn’s fistula
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P446: Plasma rich in growing factors as treatment for perianal fistulas in Crohn’s disease: unicentre experience.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P446: The INTESTINE study: INtended TEmporary STomas In crohN's diseasE
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P447 No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P447: Combined fibrin glue with infliximab therapy of postoperative anastomotic fistula in patients with Crohn`s disease:A Pilot study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P447: Early predictors of the need for surgery in patients with acute severe ulcerative colitis: results of the prospective, observational, international ESCP MASC study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P447: Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P447: Positioning of ustekinumab affects its effectiveness, drug persistence and serum exposure in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P447: Seasonal variations in Vitamin D concentrations in a single-centre inflammatory bowel disease series
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P447: The impact of therapeutic drug monitoring during biosimilar infliximab switch in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P447: Vedolizumab induces significantly higher endoscopic remission rates at week 16 in ulcerative colitis as compared to Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P448 Dose adjustment in patients with moderate-to-severe ulcerative colitis: results from the UNIFI maintenance study long-term extension
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P448: Biologic therapy and immunodulators are associated with decreased risk of cardiovascular events in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P448: Cannabis and cannabinoids for the treatment of inflammatory bowel disease: a systematic review and meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P448: IBD nurse in patients’ health status assessment: data from a pilot study comparing ability of IBD nurse and gastroenterologist in using IBD clinical scores
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P448: Long term effectiveness of first-line infliximab treatment compared to conventional treatment in paediatric moderate-to-severe Crohn's disease – an update from the TISKids study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P448: Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P448: Remission induction therapy with tacrolimus and biological combination therapy for severe ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P448: Safety of anti-TNF introduction following tuberculosis treatment in Inflammatory Bowel Disease patients in an endemic area
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM